| |
Full sample
|
Paper
|
Web
|
|---|
| | |
Respondents
|
Adj. RR2
|
95% CI
|
P
|
Respondents
|
Adj. RR2
|
95% CI
|
P
|
|---|
|
n
|
Col.%
|
n
|
Col.%
|
n
|
Col.%
|
|---|
|
Time since diagnosis
|
|
Long-term
|
192
|
43.0
|
43
|
37.7
|
1.00
|
Ref.
| |
35
|
36.8
|
1.00
|
Ref.
| |
|
Short-term
|
254
|
57.0
|
71
|
62.3
|
1.36
|
1.01, 1.84
|
0.043
|
60
|
63.2
|
1.07
|
0.74, 1.54
|
0.719
|
|
Sex
|
|
Female
|
252
|
56.5
|
74
|
64.9
|
1.39
|
0.91, 2.12
|
0.127
|
52
|
54.7
|
0.75
|
0.46, 1.22
|
0.249
|
|
Male
|
194
|
43.5
|
40
|
35.1
|
1.00
|
Ref.
| |
43
|
45.3
|
1.00
|
Ref.
| |
|
Current age
|
|
< 40
|
74
|
16.6
|
14
|
12.3
|
1.00
|
Ref.
| |
13
|
13.7
|
1.00
|
Ref.
| |
|
40–49
|
126
|
28.3
|
34
|
29.8
|
1.34
|
0.83, 2.16
|
0.238
|
30
|
31.6
|
1.49
|
0.86, 2.59
|
0.157
|
|
50–59
|
171
|
38.3
|
40
|
35.1
|
1.67
|
0.99, 2.80
|
0.053
|
34
|
35.8
|
1.06
|
0.59, 1.89
|
0.856
|
|
> =60
|
75
|
16.8
|
26
|
22.8
|
1.78
|
1.02, 3.06
|
0.043
|
18
|
19.0
|
1.56
|
0.80, 3.06
|
0.196
|
|
Race
|
|
White
|
416
|
93.3
|
108
|
94.7
|
1.00
|
Ref.
| |
92
|
96.8
|
1.00
|
Ref.
| |
|
Nonwhite
|
30
|
6.7
|
6
|
5.3
|
0.76
|
0.41, 1.41
|
0.379
|
< 53
|
–
|
0.45
|
0.16, 1.29
|
0.138
|
|
Ethnicity
|
|
Hispanic
|
68
|
15.5
|
15
|
13.4
|
0.90
|
0.60, 1.35
|
0.611
|
8
|
8.5
|
0.51
|
0.27, 0.96
|
0.036
|
|
Non-Hispanic
|
372
|
84.6
|
97
|
86.6
|
1.00
|
Ref.
| |
86
|
91.5
|
1.00
|
Ref.
| |
|
Geography
|
|
Rural
|
61
|
13.7
|
19
|
16.7
|
0.84
|
0.57, 1.21
|
0.347
|
10
|
10.5
|
0.91
|
0.55, 1.51
|
0.728
|
|
Metropolitan
|
385
|
86.3
|
95
|
83.3
|
1.00
|
Ref.
| |
85
|
89.5
|
1.00
|
Ref.
| |
|
Cancer site
|
|
Colorectal
|
128
|
28.7
|
26
|
22.8
|
1.00
|
Ref.
| |
25
|
26.3
|
1.00
|
Ref.
| |
|
Myeloma
|
64
|
14.4
|
20
|
17.5
|
1.45
|
0.77, 2.73
|
0.256
|
13
|
13.7
|
0.78
|
0.40, 1.54
|
0.480
|
|
Breast
|
97
|
21.8
|
27
|
23.7
|
0.92
|
0.57, 1.50
|
0.745
|
19
|
20.0
|
1.18
|
0.63, 2.21
|
0.597
|
|
Ovarian
|
63
|
14.1
|
21
|
18.4
|
1.26
|
0.79, 2.03
|
0.334
|
16
|
16.8
|
1.51
|
0.85, 2.68
|
0.157
|
|
Prostate
|
94
|
21.1
|
20
|
17.5
|
0.89
|
0.51, 1.56
|
0.687
|
22
|
23.2
|
1.22
|
0.72, 2.04
|
0.459
|
|
Stage
|
|
In situ
|
24
|
5.4
|
7
|
6.1
|
1.00
|
Ref.
| |
7
|
7.4
|
1.00
|
Ref.
| |
|
Localized
|
211
|
47.3
|
54
|
47.4
|
0.76
|
0.44, 1.30
|
0.313
|
39
|
41.1
|
0.74
|
0.37, 1.46
|
0.383
|
|
Regional
|
114
|
25.6
|
23
|
20.2
|
0.60
|
0.34, 1.07
|
0.086
|
26
|
27.4
|
0.86
|
0.43, 1.71
|
0.667
|
|
Distant
|
97
|
21.8
|
30
|
26.3
|
0.59
|
0.28, 1.21
|
0.149
|
23
|
24.2
|
1.11
|
0.52, 2.39
|
0.786
|
- 1. P-values for statistically significant comparisons are presented in boldface
- 2. Adjusted (Adj.) risk ratios from a multivariable model that adjusts for other variables in table
- 3. Cell counts less than five are masked for protection of confidentiality
